HIDEFRA
LIVE

Serial Number

79233561

Owner

NOVARTIS AG

Filing Date

Apr 18, 2018

Add to watchlist:

No watchlists yet
View on USPTO

HIDEFRA Trademark

Serial Number: 79233561 • Registration: 5619786

HIDEFRA is a trademark filed by NOVARTIS AG on April 18, 2018. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,135 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Sandoz AG

Viaduktstrasse 3

Entity Type: 03

Trademark Details

Filing Date

April 18, 2018

Registration Date

December 4, 2018

Published for Opposition

September 18, 2018

Cancellation Date

June 20, 2025

Goods & Services

Medical apparatus for diagnosing or treating respiratory conditions, diabetes, cardiovascular and metabolic disorders, diseases of the nervous system, inflammatory disorders, infectious diseases and for use in dermatology

Filing History

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Feb 20, 2026 INTR
CANCELLED SECTION 71
Jun 20, 2025 C71T
CHANGE OF OWNER RECEIVED FROM IB
Jan 19, 2024 CHLD
NOTIFICATION PROCESSED BY IB
Feb 1, 2019 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Jan 16, 2019 FICS
FINAL DISPOSITION PROCESSED
Jan 16, 2019 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Jan 3, 2019 GPAR
REGISTERED-PRINCIPAL REGISTER
Dec 4, 2018 R.PR
NOTIFICATION PROCESSED BY IB
Sep 21, 2018 GPNX
PUBLISHED FOR OPPOSITION
Sep 18, 2018 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 5, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 5, 2018 OP2R
NOTICE OF PUBLICATION
Aug 29, 2018 NPUB
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jul 5, 2018 PBCR
NOTICE OF PUBLICATION
Jul 4, 2018 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 19, 2018 CNSA
ASSIGNED TO EXAMINER
Jun 19, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 16, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 12, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 11, 2018 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 7, 2018 REPR